The Patent Finder

Texas Heart Institute

14 patents currently held · Updated Nov 21, 2026
21 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 12, 2027
    The maintenance fee for Trocars (US 11,751,759) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Systems and Methods for Controlling Wirelessly Powered Leadless Pacemakers (US 11,911,625) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 2 fees due Oct 5 to 30, 2027 · next Oct 5

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,301,690Device, System, and Method for a Stress Sensing Medical Needle
In force
 · High confidence
In forceHigh confidence
US 10,287,264Agonists That Enhance Binding of Integrin-Expressing Cells to Integrin Receptors
In force
 · Low confidence
In forceLow confidence
US 10,035,784Agonists that enhanced binding of integrin-expressing cells to integrin receptors
In force
 · USPTO record
In forceUSPTO record
US 10,071,980Agonists that enhanced binding of integrin-expressing cells to integrin receptors
In force
 · USPTO record
In forceUSPTO record
US 9,504,774Intraatrial ventricular assist device
In force
 · USPTO record
In forceUSPTO record
US 9,512,109Agonists that enhance binding of integrin-expressing cells to integrin receptors
In force
 · USPTO record
In forceUSPTO record
US 9,474,881Sheath and method of use
In force
 · USPTO record
In forceUSPTO record
US 10,799,333Magnetic Assisted In-Situ Tubular Stentgraft Fenestration
In force
 · High confidence
In forceHigh confidence
US 12,582,817Use of Electrically Conductive Materials for Electrophysiology
In force
 · High confidence
In forceHigh confidence
US 10,751,119Method and device for detection of arrhythmias and myocardial injury
In force
 · USPTO record
In forceUSPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 21 patents in force now held by others · 14 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 10 abandoned · 11 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited